Clinical Trials Directory

Trials / Completed

CompletedNCT06232746

Magnetic Jejuno-Ileal Diversion Study ("MJI Study")

Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System (Magnet System, DI Biofragmentable) to Achieve Jejuno-Ileal Diversion in Adults With Obesity and Type 2 Diabetes Mellitus: MJI Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
GT Metabolic Solutions, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this clinical research study is to evaluate the feasibility/performance, safety and initial efficacy of the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System (Magnet System, DI Biofragmentable and hereafter referred to as the DI Magnet System) for creation of a side-to-side jejuno-ileal anastomosis in adults with obesity and type 2 diabetes mellitus (T2DM).

Detailed description

The purpose of this clinical research study is to evaluate the feasibility/performance, safety and initial efficacy of the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System (Magnet System, DI Biofragmentable and hereafter referred to as the DI Magnet System) for creation of a side-to-side jejuno-ileal anastomosis in adults with obesity and type 2 diabetes mellitus (T2DM). This partial diversion of intestinal contents from jejunum to the ileum is intended to facilitate weight management/loss and improve metabolic outcomes. Side-by side anastomoses are currently created by sutures, staples, and anastomotic compression devices. This study explores a partial jejuno-ileal diversion procedure creating a side-to-side anastomosis with magnetic compression anastomosis.

Conditions

Interventions

TypeNameDescription
DEVICEMagnet System, DI BiofragmentableAnastomoses achieved by magnetic compression.

Timeline

Start date
2024-02-13
Primary completion
2024-09-24
Completion
2025-06-24
First posted
2024-01-31
Last updated
2025-12-23

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT06232746. Inclusion in this directory is not an endorsement.